Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1611 of 6351
-
New hope for ARDS: major trial tests multiple therapies in hospitalized patients
Disease control Recruiting nowThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Partici…
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can telehealth help treat opioid addiction in rural and minority areas?
Disease control Recruiting nowOur primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment…
Phase 1 • Sponsor: Boulder Care • Aim: Disease control
Last updated Jun 26, 2026 15:32 UTC
-
Lung cancer patients get a second shot: CyberKnife boost after chemoradiation
Disease control Recruiting nowThis is a monocentric, non-randomized, open-label, superiority phase II clinical investigation evaluating the efficacy of additional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in patients with locally advanced non-smal…
Phase 2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill targets hard-to-treat cancers with rare gene mutation
Disease control Recruiting nowThe purpose of this study is to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GenSci128 Tablet in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Blood test may unmask Alzheimer's during hospital stays
Diagnosis Recruiting nowThe goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood …
Sponsor: Covenant Health, US • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
AI tool aims to predict liver cancer return after surgery
Knowledge-focused Recruiting nowThis observational study aims to validate a deep learning model for predicting aggressive recurrence patterns in patients with early-stage liver cancer (HCC) after surgery. The main question it aims to answer is: Can the AI model accurately identify patients at high risk of canc…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:19 UTC
-
New hope for bile duct cancer: liver radiation may boost standard treatment
Disease control Recruiting nowThis study will compare outcomes for M1 iCCA patients treated with and without L-RT by reviewing iCCA patients found to have M1 disease at initial diagnosis at a single institution between 2010 and 2021 who received L-RT.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a simple supplement boost muscle strength before lung transplant?
Disease control CompletedLung transplantation (LTx) is an accepted treatment option for patients with end-stage lung disease who do not respond to non-transplant treatments. Lung transplantation (LTx) is an accepted treatment option for patients with end-stage lung disease who do not respond to non-trans…
Sponsor: Okan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a daily dose of citrus fiber tame fatty liver inflammation?
Disease control Recruiting nowThe goal of this clinical trial is to learn if daily supplementation with Low-methoxy (LM) pectin (polysaccharides extracted from citrus peels), which are commonly found in the UK diet (not pharmacological agents), can reduce systemic inflammation and improve gut microbiota compo…
Sponsor: University of Nottingham • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Pig cell transplant trial aims to stop severe low blood sugar in type 1 diabetes
Disease control Recruiting nowThis study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects wit…
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Which surgical flap hurts less? a Head-to-Head test for oroantral fistula repair
Disease control CompletedThis randomized controlled trial compares postoperative pain following surgical closure using a buccal fat pad flap versus a buccal advancement flap. The study aims to determine whether there is a difference in postoperative pain between the two surgical techniques in patients un…
Sponsor: Asma Noureen • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug aims to shrink cysts in genetic kidney disease
Disease control Recruiting nowAutosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidneys. The purpose of this study is to assess the safety and efficacy of ABBV-CLS-628 for the treatment of ADPKD in adult par…
Phase 2 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New nasal spray could help those with stubborn depression
Disease control CompletedThe purpose of this study is to evaluate how well esketamine nasal spray works in improving depressive symptoms in participants with treatment resistant depression (TRD). This will be assessed by the change from baseline in the Hamilton depression rating scale (HAM-D; 17-item) to…
Phase 4 • Sponsor: Janssen Korea, Ltd., Korea • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug combo aims to tame rare kidney disease
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic Imunoglobulin A Nephropathy (IgAN) and high risk of progression.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug shows promise for painful skin condition
Disease control OngoingThis is a phase 2b randomized, double-blind, placebo-controlled study of the safety and efficacy of tulisokibart in participants with moderate to severe hidradenitis suppurativa. The primary hypothesis is that at least 1 dose of tulisokibart is superior to placebo with respect to…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Experimental drug brincidofovir targets Hard-to-Treat lymphomas
Disease control PausedThis study is a multi-center, global, open-label, Phase 1b/2 clinical study, and it will be conducted at multiple study sites in several countries, including Japan, Korea, and Singapore, to reveal the safety, tolerability, dose limiting toxicity (DLT), maximum tolerated dose (MTD…
Phase 1/2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain zaps and poles: new combo therapy for Parkinson's gait
Symptom relief Recruiting nowParkinson's disease can cause slow or unsteady walking and balance problems that raise the risk of falls. This study will test whether adding a gentle, non-invasive brain stimulation called transcranial direct current stimulation (tDCS) during a supervised Nordic Walking program …
Sponsor: Universidade Metodista de Piracicaba • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Focused radiation may spare prostate cancer patients from harsh side effects
Symptom relief Recruiting nowThis is a phase II non-blinded randomized controlled trial of image-guided, tumor-focused radiotherapy in patients with intermediate- or high-risk prostate cancer planning to undergo definitive radiotherapy with or without systemic therapy. The image-guided, tumor-focused radioth…
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New pill could ease endometriosis pain without needles
Symptom relief OngoingTo verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Phase 3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pill could calm agitation in Alzheimer's patients
Symptom relief Recruiting nowThis is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.
Phase 2 • Sponsor: Celgene • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC